Molecular Imaging: Page 87

PET with NK1 tracer indicates pain in humans

By AuntMinnieEurope.com staff writers

PET imaging with a tracer for the signal receptor neurokinin 1 (NK1) could be useful for investigating the physiological processes of soft-tissue pain.

October 29, 2013

Siemens brings Biograph mCT to Royal Marsden

By AuntMinnieEurope.com staff writers

Siemens Healthcare has delivered two Biograph mCT hybrid PET/CT scanners to the Royal Marsden cancer center in London.

October 24, 2013

Software-based PET-MRI can prove cost-effective

By Timor Kadir, PhD; Dr. Andrew Scarsbrook; Thomas Beyer, PhD

Software PET-MRI does not offer a complete alternative to hybrid hardware PET/MRI, but commercially available software can bring PET-MRI to routine clinical practice using existing hardware, according to Timor Kadir, PhD, Dr. Andrew Scarsbrook, and Thomas Beyer, PhD.

October 24, 2013

JFR: Finger position proves vital to measure dose

By Frances Rylands-Monk

A French PET/CT study has revealed alarming gaps between radiation dose measured in different areas of the hand, calling into question the accuracy of radiation safety monitoring of staff, delegates learned this week at the Journées Françaises de Radiologie (JFR) congress in Paris.

October 23, 2013

Global imaging market could top $49B by 2020

By AuntMinnieEurope.com staff writers

The medical imaging device market could exceed $49 billion U.S. (36 billion euros) by 2020, growing at approximately 7% annually.

October 21, 2013

JFR: Are multidisciplinary meetings viable in cancer cases?

By Frances Rylands-Monk

The chronic lack of MR machines and radiologists in France was again highlighted at the national radiology congress, Journées Françaises de Radiologie (JFR), this time in a thought-provoking discussion about cancer care.

October 20, 2013

Piramal highlights florbetaben PET results

By AuntMinnieEurope.com staff writers

Radiopharmaceutical firm Piramal Imaging said four studies of its florbetaben PET agent will be presented at the European Association of Nuclear Medicine congress in Lyon, France.

October 20, 2013

EU pledges renewed support for personalized medicine

By Leo Cendrowicz

BRUSSELS - EU officials have vowed to work more closely with the medical imaging community to help roll out personalized medicine over the coming years. At a round-table gathering on 15 October, officials acknowledged that breakthroughs in technology presented medical opportunities too important to ignore.

October 15, 2013

Medical physicists' role expands in cancer care

By Cynthia E. Keen

Medical physicists are responsible for technical aspects of radiotherapy delivery, by ensuring the quality assurance of the equipment delivering radiation, and of the radiation plans that define the patient's treatment. But is this the only role of the medical physicist today?

October 9, 2013

IBA feuds with investor over molecular firm

By AuntMinnieEurope.com staff writers

Ion Beam Applications (IBA) is trading charges with investment partner SK Capital over funding of a joint-venture firm dedicated to developing new molecular compounds.

October 8, 2013

Functional MRI studies scoop top awards at ESMRMB

By Philip Ward

Researchers from the U.K. and France collected prestigious prizes at the European Society for Magnetic Resonance in Medicine and Biology (ESMRMB) meeting in Toulouse, France, for their investigations into resting state functional MRI.

October 6, 2013

Jury's still out on clinical impact of resting-state fMRI studies

By Frances Rylands-Monk

For radiologists, performing and evaluating resting-state functional MRI (fMRI) examinations will require education, availability of specific data treatment programs, and a sound understanding of the functioning of the brain in health and disease in order to make a correct decision about the patient's condition.

October 6, 2013

Previous Page

Page 87 of 122

Next Page